1. Home
  2. CARM vs GXAI Comparison

CARM vs GXAI Comparison

Compare CARM & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARM
  • GXAI
  • Stock Information
  • Founded
  • CARM 2016
  • GXAI 2021
  • Country
  • CARM United States
  • GXAI United States
  • Employees
  • CARM N/A
  • GXAI N/A
  • Industry
  • CARM Biotechnology: Pharmaceutical Preparations
  • GXAI
  • Sector
  • CARM Health Care
  • GXAI
  • Exchange
  • CARM Nasdaq
  • GXAI Nasdaq
  • Market Cap
  • CARM 8.4M
  • GXAI 9.7M
  • IPO Year
  • CARM N/A
  • GXAI 2023
  • Fundamental
  • Price
  • CARM $0.41
  • GXAI $1.57
  • Analyst Decision
  • CARM Hold
  • GXAI
  • Analyst Count
  • CARM 5
  • GXAI 0
  • Target Price
  • CARM $0.90
  • GXAI N/A
  • AVG Volume (30 Days)
  • CARM 42.2M
  • GXAI 132.6K
  • Earning Date
  • CARM 08-07-2025
  • GXAI 08-12-2025
  • Dividend Yield
  • CARM N/A
  • GXAI N/A
  • EPS Growth
  • CARM N/A
  • GXAI N/A
  • EPS
  • CARM N/A
  • GXAI N/A
  • Revenue
  • CARM $19,964,000.00
  • GXAI $27,740.00
  • Revenue This Year
  • CARM N/A
  • GXAI N/A
  • Revenue Next Year
  • CARM N/A
  • GXAI N/A
  • P/E Ratio
  • CARM N/A
  • GXAI N/A
  • Revenue Growth
  • CARM 32.45
  • GXAI 9987.27
  • 52 Week Low
  • CARM $0.14
  • GXAI $1.00
  • 52 Week High
  • CARM $1.42
  • GXAI $7.50
  • Technical
  • Relative Strength Index (RSI)
  • CARM 51.65
  • GXAI 65.71
  • Support Level
  • CARM $0.37
  • GXAI $1.30
  • Resistance Level
  • CARM $0.44
  • GXAI $1.49
  • Average True Range (ATR)
  • CARM 0.07
  • GXAI 0.09
  • MACD
  • CARM -0.01
  • GXAI 0.02
  • Stochastic Oscillator
  • CARM 10.37
  • GXAI 80.68

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.

Share on Social Networks: